As the synthetic analogues of BNP used for the treatment of HF in humans, such as nesiritide, have controversial efficacy and safety [24,25], L2 could be considered as a relevant therapeutic approach for IHD in humans. This evidence concerns the gene NPPB and myocardial ischemia.